Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
Recruiting · NCT06280755 · Observational (researchers observe without assigning treatment) · Lead sponsor: icometrix
View the official record on ClinicalTrials.gov →What this trial is about
The RECLAIM study aims to gather a centralized and harmonized dataset, enabling the secondary use of data for building AI-based models that will support diagnosis and prognosis of individual Multiple Sclerosis patient's disease course and treatment response in a real-world setting. Additionally, the data will be used to generate further insights on Multiple Sclerosis progression as well as to develop the tools to monitor this progression.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients must have a confirmed diagnosis of MS, NMOSD, MOGAD, CIS or RIS.
- Patient (or patient's legal representative) has previously signed and dated an informed consent form (ICF) for the secondary use of their data, or assent form. Alternatively, the secondary use of the patient's data is allowed following Institutional Review Board (IRB)/Ethical Committee (EC) approval in accordance with national and local subject privacy regulations.
Exclusion criteria
- Patients under 18 years of age will be excluded.
- Other unspecified reasons that, in the opinion of the Investigator or Joint Steering Committee, make the patient unsuitable for participation in the study.
Where it is running
3 locations listed.
- Katholisches Klinikum Bochum - St. Joseph-Hospital - Bochum, Bochum, Germany
- General University Hospital Prague - Prague, Praha 2, Czechia
- ERC Charité - Universitätsmedizin Berlin - Berlin, State of Berlin, Germany